Precision BioSciences appoints Sam Wadsworth and Shari Lisa Piré to Board of Directors

PRECISION BIOSCIENCES INC

Sam Wadsworth, Ph.D. (CSO, Ultragenyx Gene Therapy) appointed Class II director; brings 30 years gene therapy experience.
Shari Lisa Piré, J.D. (Chief Legal & Sustainability Officer, Plume Design) appointed Class III director; over 20 years legal/corporate experience.
New directors eligible for $40K annual cash retainer, $350K initial equity award vesting over 3 years, plus annual option awards.
Company states it aims to advance three INDs/CTAs over next three years and continue allogeneic CAR T programs.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Shari Lisa Piré

Class III director

DTIL · PRECISION BIOSCIENCES INC

Effective: 2021-11-08
Filed: November 8, 2021, 6:59 PM ET

Shari Lisa Piré to serve as a Class III director on the Company’s Board and as a member of the Nominating and Corporate Governance Committee of the Board

Appointed

Samuel Wadsworth

Class II director

DTIL · PRECISION BIOSCIENCES INC

Effective: 2021-11-08
Filed: November 8, 2021, 6:59 PM ET

Samuel Wadsworth, Ph.D. to serve as a Class II director on the Company’s Board and as a member of the Science and Technology Committee of the Board

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Shari Lisa Piré was appointed as Class III director at PRECISION BIOSCIENCES INC.

Action: appointed
Role: Class III director

Exact text from the filing

Shari Lisa Piré to serve as a Class III director on the Company’s Board and as a member of the Nominating and Corporate Governance Committee of the Board

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Samuel Wadsworth was appointed as Class II director at PRECISION BIOSCIENCES INC.

Action: appointed
Role: Class II director

Exact text from the filing

Samuel Wadsworth, Ph.D. to serve as a Class II director on the Company’s Board and as a member of the Science and Technology Committee of the Board

View on SEC.gov

PRECISION BIOSCIENCES INC filing history →

Source: SEC EDGAR

accession 0001564590-21-055061

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.